These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3970812)

  • 21. Oestrogen causes G2/M arrest and apoptosis in breast cancer cells MDA-MB-231.
    Nomoto S; Arao Y; Horiguchi H; Ikeda K; Kayama F
    Oncol Rep; 2002; 9(4):773-6. PubMed ID: 12066207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The response of breast cancer cells to steroid and peptide growth factors.
    Godden J; Leake R; Kerr DJ
    Anticancer Res; 1992; 12(5):1683-8. PubMed ID: 1444236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-proliferative effects of 1,2-diphenylethane oestrogens and anti-oestrogens on human breast cancer cells.
    Hartmann RW; Sinchai T; Kranzfelder G
    J Cancer Res Clin Oncol; 1985; 110(1):17-24. PubMed ID: 2991293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential sensitivity of human breast cancer cell lines to the growth-inhibitory effects of tamoxifen.
    Reddel RR; Murphy LC; Hall RE; Sutherland RL
    Cancer Res; 1985 Apr; 45(4):1525-31. PubMed ID: 3978620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The interaction of the steroidal antagonist faslodex and methotrexate.
    DeSoto JA; Bowen D; Southerland WM; Hawkins M; Fryar EB; Davis JH
    Cell Mol Biol (Noisy-le-grand); 2003 Nov; 49(7):1067-9. PubMed ID: 14682388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acetaminophen-induced proliferation of estrogen-responsive breast cancer cells is associated with increases in c-myc RNA expression and NF-kappaB activity.
    Gadd SL; Hobbs G; Miller MR
    Toxicol Sci; 2002 Apr; 66(2):233-43. PubMed ID: 11896290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
    Miller MA; Lippman ME; Katzenellenbogen BS
    Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative studies on the polyamine metabolism and DFMO treatment of MCF-7 and MDA-MB-231 breast cancer cell lines and xenografts.
    Kremmer T; Pälyi I; Daubner D; Boldizsár M; Vincze B; Paulik E; Sugár J; Pokorny E; Túry E
    Anticancer Res; 1991; 11(5):1807-13. PubMed ID: 1768053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The presence of a membrane-bound progesterone receptor sensitizes the estradiol-induced effect on the proliferation of human breast cancer cells.
    Neubauer H; Yang Y; Seeger H; Fehm T; Cahill MA; Tong X; Ruan X; Mueck AO
    Menopause; 2011 Aug; 18(8):845-50. PubMed ID: 21532513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of colon and breast carcinoma cell growth by interleukin-4.
    Toi M; Bicknell R; Harris AL
    Cancer Res; 1992 Jan; 52(2):275-9. PubMed ID: 1728401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oestrogenic activity of isobutylparaben in vitro and in vivo.
    Darbre PD; Byford JR; Shaw LE; Horton RA; Pope GS; Sauer MJ
    J Appl Toxicol; 2002; 22(4):219-26. PubMed ID: 12210538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture.
    Lippman M; Bolan G; Huff K
    Cancer Res; 1976 Dec; 36(12):4595-601. PubMed ID: 1000504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of a constitutive expression of transforming growth factor-alpha on the growth of MCF-7 human breast cancer cells in vitro and in vivo.
    Clarke R; Brünner N; Katz D; Glanz P; Dickson RB; Lippman ME; Kern FG
    Mol Endocrinol; 1989 Feb; 3(2):372-80. PubMed ID: 2710138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of methotrexate proline prodrug to overcome resistance by MDA-MB-231 cells.
    Wu Z; Shah A; Patel N; Yuan X
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5108-12. PubMed ID: 20674353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells.
    Lee YR; Park J; Yu HN; Kim JS; Youn HJ; Jung SH
    Biochem Biophys Res Commun; 2005 Nov; 336(4):1221-6. PubMed ID: 16169518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells.
    Spink DC; Spink BC; Cao JQ; DePasquale JA; Pentecost BT; Fasco MJ; Li Y; Sutter TR
    Carcinogenesis; 1998 Feb; 19(2):291-8. PubMed ID: 9498279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specific cytotoxicity of 16 alpha-[125I]iodoestradiol for estrogen receptor-containing breast cancer cells.
    Bronzert DA; Hochberg RB; Lippman ME
    Endocrinology; 1982 Jun; 110(6):2177-82. PubMed ID: 7075553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential growth response to oestrogen of premalignant and malignant colonic cell lines.
    Singh S; Paraskeva C; Gallimore PH; Sheppard MC; Langman MJ
    Anticancer Res; 1994; 14(3A):1037-41. PubMed ID: 8074447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined Treatment of MCF-7 Cells with AICAR and Methotrexate, Arrests Cell Cycle and Reverses Warburg Metabolism through AMP-Activated Protein Kinase (AMPK) and FOXO1.
    Fodor T; Szántó M; Abdul-Rahman O; Nagy L; Dér Á; Kiss B; Bai P
    PLoS One; 2016; 11(2):e0150232. PubMed ID: 26919657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concentration-dependent mitogenic and antiproliferative actions of 2-methoxyestradiol in estrogen receptor-positive human breast cancer cells.
    Liu ZJ; Zhu BT
    J Steroid Biochem Mol Biol; 2004 Mar; 88(3):265-75. PubMed ID: 15120420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.